Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China flag China · Delayed Price · Currency is CNY
27.40
+2.39 (9.56%)
Apr 30, 2026, 1:55 PM CST

Hubei Goto Biopharm Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 2021 - 2018
Cash & Equivalents
85.85141.18181.97438.42209.91
Upgrade
Trading Asset Securities
00015.010.1
Upgrade
Cash & Short-Term Investments
85.85141.18181.97453.43210.02
Upgrade
Cash Growth
-39.19%-22.42%-59.87%115.90%625.10%
Upgrade
Accounts Receivable
189.1214.26235.4269.36243.86
Upgrade
Other Receivables
3.32.052.151.882.09
Upgrade
Receivables
192.4216.31237.54271.25245.95
Upgrade
Inventory
473.76384.8396.16432.5371.24
Upgrade
Prepaid Expenses
----1.68
Upgrade
Other Current Assets
18.2827.754.0656.5629.37
Upgrade
Total Current Assets
770.29770869.731,214858.26
Upgrade
Property, Plant & Equipment
1,8831,8491,391610.94256.57
Upgrade
Long-Term Investments
48.2948.2748.2448.0814.47
Upgrade
Other Intangible Assets
53.7949.885143.1427.82
Upgrade
Long-Term Deferred Tax Assets
62.7737.2922.6217.898.82
Upgrade
Long-Term Deferred Charges
6.569.6913.313.960.97
Upgrade
Other Long-Term Assets
26.1225.7851.96121.5644.34
Upgrade
Total Assets
2,8512,7902,4482,0691,211
Upgrade
Accounts Payable
461.26459.91532.24205.52138.17
Upgrade
Accrued Expenses
9.6412.439.259.587.51
Upgrade
Short-Term Debt
229.75294.3110.09321.63143.41
Upgrade
Current Portion of Long-Term Debt
95.3524.5522.275.24-
Upgrade
Current Portion of Leases
-0.060.451.9811.47
Upgrade
Current Income Taxes Payable
0.430.082.87.2111.27
Upgrade
Current Unearned Revenue
6.591.233.472.013.7
Upgrade
Other Current Liabilities
19.0615.135.8422.7917.65
Upgrade
Total Current Liabilities
822.08807.69686.41575.97333.18
Upgrade
Long-Term Debt
974.16812.64652.37437.04-
Upgrade
Long-Term Leases
--0.544.416.67
Upgrade
Long-Term Unearned Revenue
144.06150.2584.3369.7142.98
Upgrade
Long-Term Deferred Tax Liabilities
0.980.010.290.970
Upgrade
Other Long-Term Liabilities
0.024.650.030.05-
Upgrade
Total Liabilities
1,9411,7751,4241,088382.83
Upgrade
Common Stock
115.28115.28115.28115.28115.28
Upgrade
Additional Paid-In Capital
409.02410.6410.77409.11409.11
Upgrade
Retained Earnings
227.41300.77330.2307.2282.67
Upgrade
Treasury Stock
-21.97----
Upgrade
Comprehensive Income & Other
96.4896.4996.4996.51-
Upgrade
Total Common Equity
826.22923.14952.75928.09807.05
Upgrade
Minority Interest
83.1491.571.0353.0721.36
Upgrade
Shareholders' Equity
909.361,0151,024981.16828.42
Upgrade
Total Liabilities & Equity
2,8512,7902,4482,0691,211
Upgrade
Total Debt
1,2991,132785.73770.3161.54
Upgrade
Net Cash (Debt)
-1,213-990.37-603.75-316.8748.47
Upgrade
Net Cash Per Share
-10.59-8.61-5.25-2.760.46
Upgrade
Filing Date Shares Outstanding
110.98115.28115.28115.28115.28
Upgrade
Total Common Shares Outstanding
110.98115.28115.28115.28115.28
Upgrade
Working Capital
-51.79-37.69183.33637.76525.08
Upgrade
Book Value Per Share
7.448.018.268.057.00
Upgrade
Tangible Book Value
772.43873.26901.75884.95779.23
Upgrade
Tangible Book Value Per Share
6.967.587.827.686.76
Upgrade
Buildings
-506.33129.73108.6795.53
Upgrade
Machinery
-820.79207.89196.16180.78
Upgrade
Construction In Progress
-694.411,182411.9966.38
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.